Multi Medika Internasional Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Multi Medika Internasional Tbk. trades at Rp745 (market cap 3.6T, 1.21M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp262 (market cap 470.58B, 11.72M 24h volume). The key difference: Multi Medika Internasional Tbk. is far larger — about 7.7× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (11.72M versus 1.21M). Which is the better fit depends on your goals.
| MMIX | PRDL | |
|---|---|---|
Market Cap | 3.6T | 470.58B |
Volume | 1.21M | 11.72M |
Lot | 12.11K | 117.18K |
Turnover | 904.56M | 3.09B |
Average Price | 747.26 | 263.29 |
Value | 904.56M | 3.09B |
Indicative Equilibrium Price | 745 | 272 |
Indicative Equilibrium Volume | 203 | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Medika Internasional Tbk (the Entity) was established based on the Notarial Deed of Ilmiawan Dekrit S., S.H., M.H., No. 23, dated September 28, 2020. The Entity commenced its commercial operations in 2020.
Read more on MMIX →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →